The World’s First Clinical Base Edting Therapy for Hemoglobinopathy
(Adnkronos) – CorrectSequence Therapeutics’ CS-101 Successfully Cures One Patient of Transfusion-Dependent β-Thalassemia SHANGHAI, Jan. 8, 2024 /PRNewswire/ — On January 8, 2024, Shanghai,China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), using innovative transformer Base
